iCoreConnect (ICCT) AI Stock Analysis

• Market Cap: $34.14K
• Dividend Yield: N/A
• Average Volume (3M): 7.64K
• Price to Earnings (P/E): ―
• Beta (1Y): -34.20
• Revenue Growth: 31.83%
• EPS Growth: -25.30%
• Country: US
• Employees: 67
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -59.67
• Shares Outstanding: 4,877,080
• 10 Day Avg. Volume: 9,555
• 30 Day Avg. Volume: 7,644
• PEG Ratio: >-0.01
• Price to Book (P/B): -0.09
• Price to Sales (P/S): 0.08
• P/FCF Ratio: -0.20
• Enterprise Value/Market Cap: 456.40
• Enterprise Value/Revenue: 1.45
• Enterprise Value/Gross Profit: 2.07
• Enterprise Value/Ebitda: -0.63
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 39 Underperform
• Price Target: $0.00 ▼(-100.00% Downside)

The overall stock score is primarily driven by weak financial performance and poor valuation metrics. The company's significant revenue growth is overshadowed by persistent profitability challenges and high leverage. Technical indicators also suggest a bearish trend, further impacting the score.

iCoreConnect Business Overview & Revenue Model

Company Description

iCoreConnect (ICCT) is a technology company specializing in providing innovative cloud-based solutions primarily for the healthcare sector. The company focuses on enhancing the operational efficiency and interoperability of healthcare practices through its core offerings, which include electronic health record (EHR) systems, practice management software, and secure communication tools. By leveraging advanced technology, iCoreConnect aims to streamline patient management, improve data accessibility, and ensure compliance with industry regulations.

How the Company Makes Money

iCoreConnect generates revenue through a subscription-based model for its software services, which includes monthly or annual fees for access to its EHR and practice management platforms. Additionally, the company earns income from ancillary services such as training, customer support, and software upgrades. Key revenue streams are bolstered by partnerships with healthcare providers, insurance companies, and technology integrators that facilitate wider adoption of its solutions. Moreover, iCoreConnect may also benefit financially from data analytics services and other value-added offerings that enhance its existing product suite.

iCoreConnect Financial Statement Overview

Summary

iCoreConnect is experiencing significant revenue growth but faces persistent profitability challenges. High leverage and negative equity pose substantial risks. While there are some improvements in cash flow, the overall financial position remains weak, requiring strategic adjustments for sustainability.

Income Statement

The company shows substantial revenue growth, with a 31.9% increase in the latest year. However, net income remains negative, reflecting ongoing losses, and both EBIT and EBITDA margins are deeply negative, highlighting continued operational challenges.

Balance Sheet

The balance sheet reveals high leverage with a negative stockholders' equity, indicating financial instability. The debt-to-equity ratio is concerning due to the negative equity, and the equity ratio is negative, reflecting more liabilities than assets.

Cash Flow

Operating and free cash flows are negative, indicating cash burn. However, there was a slight improvement in free cash flow in the latest year. The high operating cash flow to net income ratio suggests cash flow is somewhat stable relative to reported losses.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	10.75M	8.15M	7.99M	4.96M	2.12M
Gross Profit	8.25M	6.12M	5.74M	3.38M	1.11M
EBITDA	-26.73M	-11.88M	-4.00M	-3.03M	-2.35M
Net Income	-31.16M	-15.55M	-7.36M	-5.80M	-3.68M
Balance Sheet
Total Assets	5.69M	15.69M	6.56M	6.63M	2.69M
Cash, Cash Equivalents and Short-Term Investments	202.18K	1.22M	196.15K	71.81K	7.62K
Total Debt	8.85M	7.88M	6.71M	3.96M	1.58M
Total Liabilities	15.49M	11.24M	9.06M	5.63M	3.32M
Stockholders Equity	-9.79M	4.44M	-2.50M	1.01M	-628.94K
Cash Flow
Free Cash Flow	-4.63M	-9.71M	-1.57M	-3.20M	-1.81M
Operating Cash Flow	-3.23M	-8.82M	-1.27M	-2.90M	-1.27M
Investing Cash Flow	-539.42K	-10.21M	-293.96K	-3.52M	-917.90K
Financing Cash Flow	2.75M	20.06M	1.69M	6.48M	1.75M

iCoreConnect Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.01
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ICCT, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.04, and below the 200-day MA of 1.36, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 43.10 is Neutral, neither overbought nor oversold. The STOCH value of 42.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ICCT.

iCoreConnect Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
VSEE	45 Neutral	$17.36M	-0.24	-260.59%	―	713.61%	-310.54%
ICCT	39 Underperform	$34.14K	―	―	―	31.83%	-25.30%
OTRKQ	39 Underperform	$708.00	>-0.01	―	―	-21.03%	47.41%
FOXO	22 Underperform	$46.00K	―	―	―	17369.91%	69.56%